Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.61 USD | -3.99% |
|
-1.90% | -3.48% |
07/06 | Fate Therapeutics, Inc. Appoints J. Scott Wolchko as Principal Financial and Accounting Officer | CI |
31/05 | Fate Therapeutics, Inc. Announces Chief Financial Officer Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.48% | 41Cr | |
+18.15% | 12TCr | |
+18.02% | 11TCr | |
+3.81% | 2.29TCr | |
-12.75% | 2.22TCr | |
-9.86% | 1.7TCr | |
-16.64% | 1.69TCr | |
-39.94% | 1.69TCr | |
+2.80% | 1.36TCr | |
+27.39% | 1.16TCr |
- Stock Market
- Equities
- FATE Stock
- News Fate Therapeutics, Inc.
- Insider Sell: Fate Therapeutics